相关实验视频
Updated: May 18, 2026

08:16
Comparative Lesions Analysis Through a Targeted Sequencing Approach
Published on: November 5, 2019
6.8K
修改过的阿尔瓦拉多评分和拉贾伊斯特里·吉兰·阿纳克·萨莱哈尾炎 (Ripasa) 评分在东南亚人口中的比较,其中基因病理学作为黄金标准
Hummaz Mehbub1, Aftab A Baig1, Rizwan Khalid1
1General Surgery, Akhtar Saeed Medical and Dental College, Lahore, PAK.
Cureus
|November 29, 2023
概括
在东南亚人群中,Raja Isteri Pengiran Anak Saleha尾炎 (RIPASA) 评分在诊断急性尾炎方面比修改的阿尔瓦拉多评分 (MAS) 更加准确. 这种改进的诊断工具可以带来更好的患者结果.
科学领域:
- 医学诊断 医学诊断 医学诊断
- 手术紧急情况 手术紧急情况
- 胃肠道手术 胃肠道手术
背景情况:
- 诊断急性尾炎仍然具有挑战性,尽管它作为一种常见的外科紧急情况的流行.
- 修改后的阿尔瓦拉多评分 (MAS) 是广泛使用的,但在亚洲人群中显示效率降低.
- 拉贾·伊斯特里·佩金兰·阿纳克·萨勒哈尾炎 (RIPASA) 评分是为了提高亚洲人口中的尾炎诊断而开发的.
研究的目的:
- 将RIPASA评分的诊断准确性与急性尾炎的MAS进行比较.
- 为了评估东南亚人口中的这些分数,使用组织病理学作为黄金标准.
主要方法:
- 分析了150名疑似尾炎患者的研究小组.
- 每个患者的MAS和RIPASA分数都在呈现时计算出来.
- 患者接受了开放的尾切除术,切除的样本通过组织病理学检查以确认诊断.
主要成果:
- 里帕萨得分达到89.83%的灵敏度和59.38%的特异性.
- 该MAS的灵敏度为64.41%,特异性为53.12%.
- 与MAS (62.00%) 相比,RIPASA (83.33%) 的诊断准确性显著更高.
结论:
- 在诊断急性尾炎方面,RIPASA得分明显优于MAS.
- 在东南亚实施RIPASA评分可以提高诊断准确性和及时性.
- 通过RIPASA得分进行增强诊断,有可能改善患者的治疗结果.
相关概念视频
Single Nucleotide Polymorphisms-SNPs
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

